FDC gets USFDA nod for ciprofloxacin eye solution

New Delhi, Jul 2 (UNI) Drug maker FDC Ltd today said it has received the US Food and Drug Administration (USFDA) approval for ciprofloxacin ophthalmic solution.

The drug is an antibiotic used to treat eye infections, a company statement said.

The Company had recently received approval for Timolol Maleate Ophthalmic Solution.

Another ANDA Ofloxacin Ophthalmic Solution is in the final stages of approval, it added.

UNI AK MP ND114